Vimarsana
Biggest News Aggregation in the World

Page 35 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sofinnova Partners Today - Breaking & Trending Today

Endoron Medical awarded a €2.5M grant from the European Commission through the prestigious EIC Accelerator Program - Vimarsana News

Endoron Medical awarded a €2.5M grant from the European Commission through the prestigious EIC Accelerator Program

Endoron is one of 75 companies selected among nearly 1000 applicants by the European program EIC AcceleratorThe funds will enable the company to accelerate the development of its unique endovascular fastening

Investegate |Endoron Medical Announcements | Endoron Medical: Endoron Medical Awarded Grant - Vimarsana News

Investegate |Endoron Medical Announcements | Endoron Medical: Endoron Medical Awarded Grant

Investegate announcements from Endoron Medical, Endoron Medical Awarded Grant

Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer - Vimarsana News

Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Sitryx Therapeutics Announces Presentation at the Stifel 2022 Healthcare Conference - Vimarsana News

Sitryx Therapeutics Announces Presentation at the Stifel 2022 Healthcare Conference

/PRNewswire/ -- Sitryx Therapeutics Ltd (the "Company"), a biopharmaceutical company pioneering the field of immunometabolism, today announced that the Company...

Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer - Vimarsana News

Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer

The nomination bolsters the firm's management and corporate functions as it continues its expansion across the entire value chain of life sciences investments Sofinnova Partners ("Sofinnova"), a